China Listed Biopharma Companies Report, 2008

Report Overview

Table of Contents

915

Select License Type

£976.00	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,464.00	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.
£915.00	Hard Copy License Hard Copy License As described. Hard copy reports are dispatched in the post/mail. However, the majority of our reports are in PDF and are either available for immediate download or they are sent by email within hours of purchase.

£976.00	Add to Wishlist
Change Currency	GBP EURO USD

Market	Healthcare and Medical
Report Type	Market Research
Country	China
Published	9 May 2009
Number of Pages	98
Report Delivery	Email
Delivery Lead Time	-
Publisher	ResearchInChina

Sales revenue of bio-pharmaceutical industry in Jan-Nov 2008 raised 29.8% compared with the same period of 2007, up 7.6 points; Sales cost saw a 33.9% Year on year rise; and gross profit margin grew 28.2% year-on-year, down 2.5 percentage points. The rate of period expense was 15.8%, down 1.2 points from the same period of 2007.

This report firstly gives an overview of China biopharma industry, and then analyses sub-industries, import and exports status of the industry; finally it expounds the operations and revenue, project investment, main business structure, latest development and future trend of key 20 bio-pharmaceutical companies.

In 2008, China exported 1,632.14 tons of human and animal blood products, antiserum and vaccines, down 29.7% year on year; the export value totaled US$56.92 million, down 85.3%; the export price per unit was US$34.87/kg, US$16.96/kg lower than 2007.

In addition, the import volume of human and animal blood products, antiserum and vaccines amounted to 8,977.90 tons, up 2.87 times; the import value totaled US$558.16 million, up 44.3%; unit import price was US$62.17/kg, US$167.37/kg lower than 2007.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£976.00	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,464.00	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.
£915.00	Hard Copy License Hard Copy License As described. Hard copy reports are dispatched in the post/mail. However, the majority of our reports are in PDF and are either available for immediate download or they are sent by email within hours of purchase.

£976.00	Add to Wishlist
Change Currency	GBP EURO USD

1.Overview of China Bio-pharmaceutical Industry, 2008
1.1 Industry Development
1.2 Market
1.2.1 Overview
1.2.2 Sub-industries
1.2.3 Import & Export

2. Shenzhen CAU Technology Co., Ltd (000004)
2.1 Company Profile
2.2 Operations and Revenue
2.3 Investment
2.4 Main Business Structure
2.5 Latest Development and Future Trend

3.Shenzhen Neptunus Bioengineering Co., Ltd (000078)
3.1 Company Profile
3.2 Operations and Revenue
3.3 Investment
3.4 Main Business Structure
3.5 Latest Development and Future Trend

4.Sihuan Pharmaceutical Co., Ltd (000605)
4.1 Company Profile
4.2 Operations and Revenue
4.3 Investment
4.4 Main Business Structure
4.5 Latest Development and Future Trend

5.Changchun High & New Technology Industries (Group) Inc. (000661)
5.1 Company Profile
5.2 Operations and Revenue
5.3 Investment
5.4 Main Business Structure
5.5 Latest Development and Future Trend

6.Chengzhi Co., Ltd (000990)
6.1 Company Profile
6.2 Operations and Revenue
6.3 Investment
6.4 Main Business Structure
6.5 Latest Development and Future Trend

7. Hualan Biological Engineering Inc.(002007)
7.1 Company Profile
7.2 Operations and Revenue
7.3 Investment
7.4 Main Business Structure
7.5 Latest Development and Future Trend

8.Shanghai Kehua Bio-engineering Co., Ltd (002022)
8.1 Company Profile
8.2 Operations and Revenue
8.3 Investment
8.4 Main Business Structure
8.5 Latest Development and Future Trend

9.Da An Gene Co., Ltd (002030)
9.1 Company Profile
9.2 Operations and Revenue
9.3 Investment
9.4 Main Business Structure
9.5 Latest Development and Future Trend

10.Beijing SL Pharmaceutical Co., Ltd (002038)
10.1 Company Profile
10.2 Operations and Revenue
10.3 Investment
10.4 Main Business Structure
10.5 Latest Development and Future Trend

11.Shanghai RAAS Blood Products Co., Ltd (002252)
11.1 Company Profile
11.2 Operations and Revenue
11.3 Investment
11.4 Main Business Structure
11.5 Latest Development and Future Trend

12.Ginwa Enterprise (Group) Co., Ltd (600080)
12.1 Company Profile
12.2 Operations and Revenue
12.3 Investment
12.4 Main Business Structure
12.5 Latest Development and Future Trend

13.Beijing Tiantan Biological Products Co., Ltd (600161)
13. 1 Company Profile
13.2 Operations and Revenue
13.3 Investment
13.4 Main Business Structure
13.5 Latest Development and Future Trend

14.China Animal Husbandry Industry Co., Ltd (600195)
14.1 Company Profile
14.2 Operations and Revenue
14.3 Investment
14.4 Main Business Structure
14.5 Latest Development and Future Trend

15.Shanghai Fosun Pharmaceutical (Group) Co., Ltd (600196)
15.1 Company Profile
15.2 Operations and Revenue
15.3 Investment
15.4 Main Business Structure
15.5 Latest Development and Future Trend

16.Inner Mongolia Jinyu Group Co., Ltd (600201)
16.1 Company Profile
16.2 Operations and Revenue
16.3 Investment
16.4 Main Business Structure
16.5 Latest Development and Future Trend

17.Shanghai Jiao Da Onlly Co., Ltd (600530)
17.1 Company Profile
17.2 Operations and Revenue
17.3 Investment
17.4 Main Business Structure
17.5 Latest Development and Future Trend

18.Beihai Gofar Marine Biological Industry Co., Ltd (600538)
18.1 Company Profile
18.2 Operations and Revenue
18.3 Investment
18.4 Main Business Structure
18.5 Latest Development and Future Trend

19.Zhongyuan Union Stem Cell Bioengineering Co., Ltd (600645)
19.1 Company Profile
19.2 Operations and Revenue
19.3 Investment
19.4 Main Business Structure
19.5 Latest Development and Future Trend

20.Star Lake Bioscience Co., Inc (600866)
20.1 Company Profile
20.2 Operations and Revenue
20.3 Investment
20.4 Main Business Structure
20.5 Latest Development and Future Trend

21.Tonghua Dongbao Pharmaceutical Co., Ltd (600867)
21.1 Company Profile
21.2 Operations and Revenue
21.3 Main Business Structure
21.4 Latest Development and Future TrendGrowth of Quarterly Revenue of Bio-pharmaceutical Industry, 2005Q1-2009Q1
Growth of Quarterly Total Profit of Bio-pharmaceutical Industry, 2005Q1-2009Q1
YoY Growth Rate of Sales Revenue and Total profit of Bio-pharmaceutical Industry, Jan-Nov 2008
Gross Profit Margin and Pre-tax Margin of Bio-pharmaceutical Industry, Jan-Nov2008
Top Six Immune Vaccines In Terms of Planned Investment in China
Market Share of MMR Triple Vaccine in China, 2007 Market Share of Influenza Vaccine in China, 2007
Market Share of Antineoplastics in China
Market Share of Plant-based Antitumor Drugs in China
Rank of China’s Docetaxel Producers
Import of China’s Human & Animal Blood Products, Antiserum and Vaccine, Jan-Dec 2008
Export of China’s Human & Animal Blood Products, Antiserum and Vaccine, Jan-Dec 2008
Revenue and Net Profit of Shenzhen CAU Technology Co., Ltd, 2003-2008
Total Asset and Monetary Capital of Shenzhen CAU Technology Co., Ltd, 2003-2008
Revenue Structure of Shenzhen CAU Technology Co., Ltd by Product, 2008
Revenue Structure of Shenzhen CAU Technology Co., Ltd by Sector, 2008
Revenue Structure of Shenzhen CAU Technology Co., Ltd by Region, 2008
Revenue and Net Profit of Shenzhen Neptunus Bioengineering Co., Ltd, 2003-2008
Total Asset and Monetary Capital of Shenzhen Neptunus Bioengineering Co., Ltd, 2003-2008
Revenue Structure of Shenzhen Neptunus Bioengineering Co., Ltd by Sector, 2008
Revenue and Net Profit of Sihuan Pharmaceutical Co., Ltd, 2003-2008
Total Asset and Monetary Capital of Sihuan Pharmaceutical Co., Ltd, 2003-2008
Revenue Structure of Sichuan Pharmaceutical Co., Ltd by Product, 1H 2008
Revenue and Net Profit of Changchun High & New Technology Industries (Group) Inc., 2003-2008
Total Asset and Monetary Capital Changchun High & New Technology Industries (Group) Inc., 2003-2008
Revenue Structure of Changchun High & New Technology Industries (Group) Inc. by Product, 2008
Indices of Main Business Revenue, Cost and Gross Profit Margin of Changchun High & New Technology Industries (Group) Inc., 2008
Operating Profit Proportion of Changchun High & New Technology Industries (Group) Inc., 2008
Revenue and Net Profit of Chengzhi Co., Ltd, 2003-2008
Total Asset and Monetary Capital of Chengzhi Co., Ltd, 2003-2008
Revenue Structure of Chengzhi Co., Ltd by Sector, 2008
Revenue Structure of Chengzhi Co., Ltd by Business, 2007-2008
Quarterly Revenue and Growth Rate of Profit of Chengzhi Co., Ltd, 2008
Shareholding Structure of Hualan Biological Engineering Inc.
Revenue and Net Profit of Hualan Biological Engineering Inc., 2003-2008 Total Asset and Monetary Capital of Hualan Biological Engineering Inc., 2003-2008 Revenue Structure of Hualan Biological Engineering Inc. by Product, 2008
Issued Quantity Proportion of Influenza Vaccines in China, 2008
Issued Quantity of Influenza Vaccines in China, 2007-2008
Issued Quantity Proportion of Hepatitis B Vaccines in China, 2008
Issued Quantity Proportion of ACYW135 Vaccine of Hualan Biological Engineering Inc., 2008
Revenue and Net Profit of Shanghai Kehua Bio-engineering Co., Ltd 2003-2008
Total Asset and Monetary Capital of Shanghai Kehua Bio-engineering Co., Ltd, 2003-2008
Revenue Structure of Shanghai Kehua Bio-engineering Co., Ltd by Product, 2008
Sales Growth of Hepatitis Immune Products of Shanghai Kehua Bio-engineering Co., Ltd, 2005-2008
Net Profit Margin of Hepatitis Immune Products of Shanghai Kehua Bio-engineering Co., Ltd, 2005-2008
Apparatus Sales Ratio of Shanghai Kehua Bio-engineering Co. increased from 2005-2008
Revenue and Net Profit of Da An Gene Co., Ltd, 2003-2008
Total Asset and Monetary Capital of Da An Gene Co., Ltd, 2003-2008
Revenue Structure of Da An Gene Co., Ltd by Product, 2008
China In-Vitro Diagnostics Sub-industries, 2008
Revenue and Net Profit of Beijing SL Pharmaceutical Co., Ltd, 2003-2008
Total Asset and Monetary Capital Beijing SL Pharmaceutical Co., Ltd, 2003-2008
Revenue Structure of Beijing SL Pharmaceutical Co., Ltd by Product, 2008
Quarterly Revenue and Net Profit of Beijing SL Pharmaceutical Co., Ltd, 2005-2008
Quarterly Profitability of Beijing SL Pharmaceutical Co., Ltd, 2005-2008
Revenue and Net Profit of Shanghai RAAS Blood Products Co., Ltd, 2005-2008
Total Asset and Monetary Capital of Shanghai RAAS Blood Products Co., Ltd, 2005-2008
Revenue Structure of Shanghai RAAS Blood Products Co., Ltd by Product, 2008
Sales by Product of Shanghai RAAS Blood Products Co., Ltd, 2007-2008
Sales Gross Profit Margin of Shanghai RAAS Blood Products Co., Ltd, 2008
Revenue from HSA and Intravenous Gammaglobulin, 2005-2008
Changes of Plasma Circulation in China
Revenue and Net Profit of Ginwa Enterprise (Group) Co., Ltd, 2003-2008
Total Asset and Monetary Capital of Ginwa Enterprise (Group) Co., Ltd, 2003-2008
Revenue Structure by Sector of Ginwa Enterprise (Group) Co., Ltd, 2008
Revenue and Net Profit of Beijing Tiantan Biological Products Co., Ltd, 2003-2008
Total Asset and Monetary Capital of Beijing Tiantan Biological Products Co., Ltd, 2003-2008
Revenue Structure of Beijing Tiantan Biological Products Co., Ltd by Product, 2008
Sales of Vaccine & Blood Products of Beijing Tiantan Biological Products Co., Ltd, 2006-2008
Issued Quantity of MMR Triple Vaccines of Beijing Tiantan Biological Products Co., Ltd, 2008-2009Q1
Issued Quantity of Hepatitis B Vaccines of Beijing Tiantan Biological Products Co., Ltd, 2008-2009Q1
Product Structure of Chengdu Rongsheng Pharmaceuticals Co., Ltd before It Was Purchased
Issued Quantity of HAS in China, 2008 Issued Quantity of Intravenous Gammaglobulin in China, 2008
Revenue and Net Profit of China Animal Husbandry Industry Co., Ltd, 2003-2008
Total Asset and Monetary Capital of China Animal Husbandry Industry Co., Ltd, 2003-2008
Revenue Structure of China Animal Husbandry Industry Co., Ltd by Sector, 2008
Revenue Structure of China Animal Husbandry Industry Co., Ltd, 2004-2008
Main Operating Profit Structure of China Animal Husbandry Industry Co., Ltd, 2004-2008
Main Operating Profit Rate of China Animal Husbandry Industry Co. by Product, 2004-2008
Key Immune Solutions to Animal Epidemic Issued by China Ministry of Agriculture, 2009
Revenue and Net Profit of Shanghai Fosun Pharmaceutical (Group) Co., Ltd, 2003-2008
Total Asset and Monetary Capital of Shanghai Fosun Pharmaceutical (Group) Co., Ltd, 2003-2008
Revenue Structure of Shanghai Fosun Pharmaceutical (Group) Co., Ltd by Product, 2008
Quarterly Performance of Shanghai Fosun Pharmaceutical (Group) Co., Ltd, 2007-2008
Main Business Revenue Proportion of Shanghai Fosun Pharmaceutical (Group) Co., 2008
Main Business Profit Proportion of Shanghai Fosun Pharmaceutical (Group) Co., Ltd, 2008
Performances of Main Businesses Shanghai Fosun Pharmaceutical (Group) Co., Ltd, 2004-2008
Revenue and Net Profit of Inner Mongolia Jinyu Group Co., Ltd, 2003-2008
Total Asset and Monetary Capital of Inner Mongolia Jinyu Group Co., Ltd, 2003-2008
Revenue Structure of Inner Mongolia Jinyu Group Co., Ltd by Product, 2008
Main Business Revenue Structure of Inner Mongolia Jinyu Group Co., Ltd, 2005-2008
Main Business Profit Structure of Inner Mongolia Jinyu Group Co., Ltd, 2005-2008
Revenue form Animal Vaccine and Main operating Profit Rate of Inner Mongolia Jinyu Group Co., Ltd, 2005-2008
Revenue and Net Profit of Shanghai Jiao Da Onlly Co., Ltd, 2003-2008
Total Asset and Monetary Capital of Shanghai Jiao Da Onlly Co., Ltd, 2003-2008
Revenue Structure of Shanghai Jiao Da Onlly Co., Ltd by Sector, 2008
Revenue and Net Profit of Beihai Gofar Marine Biological Industry Co., Ltd, 2003-2008
Total Asset and Monetary Capital of Beihai Gofar Marine Biological Industry Co., Ltd 2003-2008
Revenue Structure of Beihai Gofar Marine Biological Industry Co., Ltd by Sector, 2008
Revenue and Net Profit of Zhongyuan Union Stem Cell Bioengineering Co., Ltd 2003-2008
Total Asset and Monetary Capital of Zhongyuan Union Stem Cell Bioengineering Co., Ltd 2003-2008
Revenue Structure by Sector of Zhongyuan Union Stem Cell Bioengineering Co., Ltd, 2008
Revenue and Net Profit of Star Lake Bioscience Co., Ltd, 2003-2008
Total Asset and Monetary Capital of Star Lake Bioscience Co., Ltd, 2003-2008
Revenue Structure of Star Lake Bioscience Co., Ltd by Product, 2008
Shareholding Structure of Tonghua Dongbao Pharmaceutical Co., Ltd.
Revenue and Net Profit of Tonghua Dongbao Pharmaceutical Co., Ltd, 2003-2008
Total Asset and Monetary Capital of Tonghua Dongbao Pharmaceutical Co., Ltd, 2003-2008
Revenue Structure of Tonghua Dongbao Pharmaceutical Co. by Product, 2008
Sales and Profitability Analysis by Products of Tonghua Dongbao Pharmaceutical Co., Ltd, 2007-2008
Revenue from Recombinant Human Insulin of Tonghua Dongbao Pharmaceutical Co., Ltd, 2005-2008
Revenue Proportion of Recombinant Human Insulin Tonghua Dongbao Pharmaceutical Co., Ltd, 2005-2008
Net Profit and Asset of Key Subsidiary Companies of Tonghua Dongbao Pharmaceutical Co., Ltd, 2004-2008

Change Currency

GBP

EURO

USD

Last Viewed

China Listed Biopharma Companies Report, 2008

Thailand Defence and Security Report Q4 2009

Scotiabank - Nuclear Energy - Advisory Profile

Key Construction Markets Intelligence Report

Brazil Information Technology Report Q4 2009

Healthcare and Medical Company Profiles

Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

China Listed Biopharma Companies Report, 2008

Select License Type

Speak to an Advisor

Select License Type

Table of Contents

Change Currency

Last Viewed

Healthcare and Medical Company Profiles

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel